Pembrolizumab plus chemotherapy with or without bevacizumab could be a new standard of care for first-line therapy in metastatic cervical cancer.

Yasser El-Shimy, PhD, MBA, is a Senior Investment Analyst at The Motley Fool. Yasser is a Lead Advisor for the Global Partners scorecard where he specializes in international stocks and markets. Prior ...

Public-private collaboration and structured evidence consolidation are emerging as critical enablers of regulatory-ready digital endpoints, helping standardize terminology, reduce duplication, and ...

MADISON, Wis.--(BUSINESS WIRE)--Nimble Therapeutics, an industry-leading peptide therapeutic discovery and optimization company, today announced the appointment of Dr. Cyrus Arman as Chief Business ...